School of Basic Medicine, Medical College, Qingdao University, Qingdao, China.
College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China.
Invest Ophthalmol Vis Sci. 2022 Jul 8;63(8):15. doi: 10.1167/iovs.63.8.15.
To explore the effect and mechanism of NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasomes on corneal fibrosis.
The wild-type, NLRP3 knockout (KO), and myeloid cell-specific NLRP3 KO (NLRP3 Lyz-KO) C57 mice were used to establish a corneal scarring model. NLRP3 inhibitor, IL-1β neutralizing antibody, and an IL-1R antagonist were used to investigate the role of NLRP3 and IL-1β in corneal fibrosis. The expression of the NLRP3 signaling pathway related proteins, alpha-smooth muscle actin, TGF-β was determined by quantitative real-time polymerase chain reaction, Western blotting, and immunofluorescence staining. Flow cytometry was used to detect the infiltration of macrophages during corneal fibrosis.
The components of the NLRP3 inflammasomes were elevated and activated during corneal scarring. Additionally, genetic or chemical-mediated blocking of NLRP3 as well as IL-1β significantly alleviated corneal fibrosis. Moreover, neutrophil (CD45+Ly6G+) and macrophage (CD45+ F4/80+) accumulation increased in the cornea during the progression of corneal fibrosis. Intriguingly, the increased concentrations of NLRP3 and IL-1β were prominently colocalized with the infiltrating F4/80+ macrophages. Expectedly, NLRP3 Lyz-KO mice exhibited a marked decrease in their corneal fibrosis symptoms. Mechanistically, the activation of IL-1β or macrophage NLRP3 stimulated the expression of TGF-β1 in the corneal epithelial cells, whereas an NLRP3 deficiency decreased its expression in the corneal epithelium.
These observations revealed that the NLRP3 inflammasome activation in infiltrating macrophages contributes to corneal fibrosis by regulating corneal epithelial TGF-β1 expression. Targeting the NLRP3 inflammasome might be a promising strategy for the treatment of corneal scarring.
探讨 NOD、LRR 和 pyrin 结构域包含蛋白 3(NLRP3)炎症小体在角膜纤维化中的作用和机制。
使用野生型、NLRP3 敲除(KO)和髓样细胞特异性 NLRP3 KO(NLRP3 Lyz-KO)C57 小鼠建立角膜瘢痕模型。使用 NLRP3 抑制剂、IL-1β 中和抗体和 IL-1R 拮抗剂来研究 NLRP3 和 IL-1β 在角膜纤维化中的作用。通过定量实时聚合酶链反应、Western 印迹和免疫荧光染色来确定 NLRP3 信号通路相关蛋白、α-平滑肌肌动蛋白和 TGF-β 的表达。流式细胞术用于检测角膜纤维化过程中巨噬细胞的浸润。
在角膜瘢痕形成过程中,NLRP3 炎症小体的组成部分升高并被激活。此外,通过遗传或化学手段阻断 NLRP3 以及 IL-1β 可显著减轻角膜纤维化。此外,在角膜纤维化进展过程中,角膜中中性粒细胞(CD45+Ly6G+)和巨噬细胞(CD45+F4/80+)的积累增加。有趣的是,增加的 NLRP3 和 IL-1β 浓度与浸润的 F4/80+巨噬细胞明显共定位。预期地,NLRP3 Lyz-KO 小鼠的角膜纤维化症状明显减轻。机制上,IL-1β 或巨噬细胞 NLRP3 的激活刺激角膜上皮细胞中 TGF-β1 的表达,而 NLRP3 缺乏则降低角膜上皮细胞中其表达。
这些观察结果表明,浸润巨噬细胞中 NLRP3 炎症小体的激活通过调节角膜上皮细胞 TGF-β1 的表达促进角膜纤维化。靶向 NLRP3 炎症小体可能是治疗角膜瘢痕的一种有前途的策略。